Physician profile
Michael B Pickard
NPI 1457570301
$8,909.34
in general payments reported to CMS, 2019-2025
7 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what 96% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $787 · 2021: $359 · 2022: $2,045 · 2023: $751 · 2024: $2,383 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,662 · Gift: $1,590 · Travel and Lodging: $727 · Education: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,661.57 |
| Gift | $1,590.00 |
| Travel and Lodging | $726.99 |
| Education | $453.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $2,991.62 | 2019-2025 | Master Series, LP and Ifit Tubes, Empower-Metal |
| Align Technology, INC. | $2,721.70 | 2019-2025 | Invisalign, Itero Element 5d Plus Lite, Vivera Retainers |
| Purelife, LLC | $1,690.00 | 2020-2025 | |
| Gc America INC. | $789.28 | 2023-2025 | Bio-Active, Chic, Experience |
| Envista Holdings Corporation | $559.36 | 2024 | Ultima, Spark |
| Ormco Corporation | $103.69 | 2022-2023 | Red, White and Blue Retainer |
| Nobel Biocare USA | $53.69 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pickard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.